Sunday, July 13, 2025

Ranbaxy forfeits 180 days exclusivity for stomach drugs

Last Updated: Tuesday, January 27, 2015, 13:16

Drug major Ranbaxy on Tuesday said that the US health regulator has "determined" that the Indian drug manufacturer has forfeited its 180 days exclusivity for stomach and esophagus problems treatment tablets.

German regulator hails EMA's drugs suspension on GVK Bio data

Last Updated: Saturday, January 24, 2015, 13:34

German drug regulator has welcomed the European Medicine Agency's (EMA) decision to suspend the marketing authorisation of around 700 generic drugs subjected to clinical trials by India's GVK Biosciences.